Wedbush Starts NovoCure Ltd. (NVCR) at Outperform

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/22/2026

1. SPCX
2. NVDA
3. NFLX
4. ISRG
5. META
6. TSLA
7. SMCI
8. RTX
9. GOOGL
10. S

Go back to Wedbush Starts NovoCure Ltd. (NVCR) at Outperform

Novocure Reports Third Quarter 2015 Operating and Financial Results

October 26, 2015 4:05 PM EDT

FDA approved Optune in combination with temozolomide for the treatment of newly diagnosed glioblastoma on October 5, 2015

CE Mark was placed on the second generation Optune system. First patients treated in Europe with the newly designed, smaller, lighter system

468 active patients at quarter end, an increase of 161% versus the prior year quarter end

ST. HELIER, Jersey--(BUSINESS WIRE)-- Novocure (NASDAQ: NVCR), a commercial stage oncology company pioneering a novel therapy for solid tumors, today reported operating and financial results for the three and nine months ended September 30, 2015.

... More